TABLE 6

The potency and efficacy of ligands at D3/2 receptor-G protein fusions

Experiments were performed in triplicate to n = 3. %DA, Emax value of [35S]GTPγS binding compared with maximal dopamine stimulation. The potency of the ligands that were able to activate each of the four different D3/2 receptor-Gα subunit fusion proteins were compared using a one-way ANOVA with a Bonferroni post-hoc test. Significant differences in pEC50 between D3/2 receptor fusion proteins for dopamine, D3/2o1 = D3/2i3 > D3/2i2 = D3/2i1 (p < 0.001); and quinpirole, D3/2o1 = D3/2i3 > D3/2i2 = D3/2i1 (p < 0.01).



D3/2i1

D3/2i2

D3/2i3

D3/2o1

pEC50 (±S.E.M.)
Emax
pEC50 (±S.E.M.)
Emax
pEC50 (±S.E.M.)
Emax
pEC50
Emax
%DA (±S.E.M.) %DA (±S.E.M.) %DA (±S.E.M.) %DA (±S.E.M.)
Dopamine 5.3 (0.06) 100 5.6 (0.18) 100 7.2 (0.32) 100 7.3 (0.12) 100
m-Tyramine N.A. 4.1 (0.16) 53 (9) 6.2 (0.17) 81 (9) 6.4 (0.09) 79 (3)
p-Tyramine N.A. N.A. 5.5 (0.14) 45 (5) 5.2 (0.16) 80 (1)
R-(+)-3-PPP N.A. 4.1 (0.24) 68 (11) 6.1 (0.08) 68 (7) 6.0 (0.14) 92 (4)
S-(-)-3-PPP N.A. N.A. 6.7 (0.36) 40 (3) 6.9 (0.10) 50 (4)
Quinpirole 5.6 (0.09) 120 (13) 5.3 (0.69) 120 (3) 7.4 (0.21) 100 (4) 7.6 (0.08) 100 (3)
NPA 9.4 (0.08) 120 (12) 8.6 (0.06) 120 (1) 9.3 (0.03) 91 (3) 9.1 (0.02) 110 (2)
7-OH-DPAT
10 (0.19)
76 (8)
N.A.

11 (0.88)
34 (5)
10 (0.03)
64 (1)
  • N.A., no detectable stimulation.